Fluid Response Evaluation in Sepsis Hypotension and Shock: A Randomized Clinical Trial.


Journal

Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335

Informations de publication

Date de publication:
10 2020
Historique:
received: 04 02 2020
revised: 16 03 2020
accepted: 02 04 2020
pubmed: 1 5 2020
medline: 4 6 2021
entrez: 1 5 2020
Statut: ppublish

Résumé

Fluid and vasopressor management in septic shock remains controversial. In this randomized controlled trial, we evaluated the efficacy of dynamic measures (stroke volume change during passive leg raise) to guide resuscitation and improve patient outcome. Will resuscitation that is guided by dynamic assessments of fluid responsiveness in patients with septic shock improve patient outcomes? We conducted a prospective, multicenter, randomized clinical trial at 13 hospitals in the United States and United Kingdom. Patients presented to EDs with sepsis that was associated hypotension and anticipated ICU admission. Intervention arm patients were assessed for fluid responsiveness before clinically driven fluid bolus or increase in vasopressors occurred. The protocol included reassessment and therapy as indicated by the passive leg raise result. The control arm received usual care. The primary clinical outcome was positive fluid balance at 72 hours or ICU discharge, whichever occurred first. In modified intent-to-treat analysis that included 83 intervention and 41 usual care eligible patients, fluid balance at 72 hours or ICU discharge was significantly lower (-1.37 L favoring the intervention arm; 0.65 ± 2.85 L intervention arm vs 2.02 ± 3.44 L usual care arm; P = .021. Fewer patients required renal replacement therapy (5.1% vs 17.5%; P = .04) or mechanical ventilation (17.7% vs 34.1%; P = .04) in the intervention arm compared with usual care. In the all-randomized intent-to-treat population (102 intervention, 48 usual care), there were no significant differences in safety signals. Physiologically informed fluid and vasopressor resuscitation with the use of the passive leg raise-induced stroke volume change to guide management of septic shock is safe and demonstrated lower net fluid balance and reductions in the risk of renal and respiratory failure. Dynamic assessments to guide fluid administration may improve outcomes for patients with septic shock compared with usual care. NCT02837731.

Sections du résumé

BACKGROUND
Fluid and vasopressor management in septic shock remains controversial. In this randomized controlled trial, we evaluated the efficacy of dynamic measures (stroke volume change during passive leg raise) to guide resuscitation and improve patient outcome.
RESEARCH QUESTION
Will resuscitation that is guided by dynamic assessments of fluid responsiveness in patients with septic shock improve patient outcomes?
STUDY DESIGN AND METHODS
We conducted a prospective, multicenter, randomized clinical trial at 13 hospitals in the United States and United Kingdom. Patients presented to EDs with sepsis that was associated hypotension and anticipated ICU admission. Intervention arm patients were assessed for fluid responsiveness before clinically driven fluid bolus or increase in vasopressors occurred. The protocol included reassessment and therapy as indicated by the passive leg raise result. The control arm received usual care. The primary clinical outcome was positive fluid balance at 72 hours or ICU discharge, whichever occurred first.
RESULTS
In modified intent-to-treat analysis that included 83 intervention and 41 usual care eligible patients, fluid balance at 72 hours or ICU discharge was significantly lower (-1.37 L favoring the intervention arm; 0.65 ± 2.85 L intervention arm vs 2.02 ± 3.44 L usual care arm; P = .021. Fewer patients required renal replacement therapy (5.1% vs 17.5%; P = .04) or mechanical ventilation (17.7% vs 34.1%; P = .04) in the intervention arm compared with usual care. In the all-randomized intent-to-treat population (102 intervention, 48 usual care), there were no significant differences in safety signals.
INTERPRETATION
Physiologically informed fluid and vasopressor resuscitation with the use of the passive leg raise-induced stroke volume change to guide management of septic shock is safe and demonstrated lower net fluid balance and reductions in the risk of renal and respiratory failure. Dynamic assessments to guide fluid administration may improve outcomes for patients with septic shock compared with usual care.
CLINICAL TRIAL REGISTRATION
NCT02837731.

Identifiants

pubmed: 32353418
pii: S0012-3692(20)30768-6
doi: 10.1016/j.chest.2020.04.025
pmc: PMC9490557
pii:
doi:

Substances chimiques

Vasoconstrictor Agents 0

Banques de données

ClinicalTrials.gov
['NCT02837731']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1431-1445

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR002369
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Crit Care. 2015 Jun 15;19:251
pubmed: 26073560
Crit Care Med. 2018 Jun;46(6):997-1000
pubmed: 29767636
Crit Care Med. 2008 Jan;36(1):69-73
pubmed: 18090369
N Engl J Med. 2017 Jun 8;376(23):2223-2234
pubmed: 28320242
Crit Care Med. 2011 Feb;39(2):259-65
pubmed: 20975548
Crit Care Med. 2006 Feb;34(2):344-53
pubmed: 16424713
Chest. 2013 Feb 1;143(2):364-370
pubmed: 22910834
Crit Care Med. 2006 May;34(5):1402-7
pubmed: 16540963
J Intensive Care. 2016 Oct 6;4:63
pubmed: 27721980
Eur Respir J. 2013 Jul;42(1):125-33
pubmed: 23100501
Anesth Analg. 2014 May;118(5):966-75
pubmed: 24681660
Nat Rev Nephrol. 2010 Feb;6(2):107-15
pubmed: 20027192
Intensive Care Med. 2007 Jul;33(7):1191-1194
pubmed: 17458538
Intensive Care Med. 2017 Mar;43(3):304-377
pubmed: 28101605
Chest. 2002 Jun;121(6):2000-8
pubmed: 12065368
Crit Care Med. 1993 Feb;21(2):218-23
pubmed: 8428472
Br J Anaesth. 2018 Apr;120(4):734-744
pubmed: 29576114
N Engl J Med. 2001 Nov 8;345(19):1368-77
pubmed: 11794169
J Pharmacol Toxicol Methods. 2011 Sep-Oct;64(2):111-8
pubmed: 21440649
Am J Emerg Med. 2016 Nov;34(11):2122-2126
pubmed: 27553826
J Crit Care. 2018 Dec;48:153-159
pubmed: 30199843
Intensive Care Med. 2016 Dec;42(12):1935-1947
pubmed: 26825952
J Intensive Care Med. 2020 Oct;35(10):1123-1128
pubmed: 30572756
N Engl J Med. 2006 Jun 15;354(24):2564-75
pubmed: 16714767
JAMA. 2014 Jun 4;311(21):2181-90
pubmed: 24842135
Trials. 2017 Aug 29;18(1):399
pubmed: 28851407
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H583-9
pubmed: 17384132
Am J Emerg Med. 2015 Feb;33(2):186-9
pubmed: 25483379
Stat Med. 2011 Dec 10;30(28):3267-84
pubmed: 22105690
Crit Care Med. 2013 Jul;41(7):1774-81
pubmed: 23774337
Intensive Care Med. 2017 May;43(5):625-632
pubmed: 28130687
JAMA. 2016 Sep 27;316(12):1298-309
pubmed: 27673307
Shock. 2015 Jan;43(1):68-73
pubmed: 25247784
J Clin Monit Comput. 2008 Apr;22(2):113-9
pubmed: 18340540
Ann Am Thorac Soc. 2015 Dec;12(12):1837-44
pubmed: 26394090
J Crit Care. 2017 Dec;42:42-46
pubmed: 28672146

Auteurs

Ivor S Douglas (IS)

Pulmonary Science and Critical Care Medicine, Denver Health Medical Center and University of Colorado, Anschutz Medical Campus, Denver, CO. Electronic address: ivor.douglas@dhha.org.

Philip M Alapat (PM)

Pulmonary, Critical Care and Sleep Medicine, Ben Taub Hospital, Houston, TX.

Keith A Corl (KA)

Pulmonary, Critical Care and Sleep Medicine, Rhode Island Hospital, Providence, RI.

Matthew C Exline (MC)

Pulmonary, Critical Care and Sleep Medicine, Ohio State University Hospital, Columbus, OH.

Lui G Forni (LG)

Intensive Care Medicine and Nephrology, University of Surrey & Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK.

Andre L Holder (AL)

Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University, Atlanta, GA.

David A Kaufman (DA)

NYU School of Medicine, New York, NY; Pulmonary and Critical Care Medicine, Bridgeport Hospital, Bridgeport, CT.

Akram Khan (A)

Pulmonary and Critical Care Medicine, Oregon Health and Science University, Portland, OR.

Mitchell M Levy (MM)

Pulmonary, Critical Care and Sleep Medicine, Rhode Island Hospital, Providence, RI.

Gregory S Martin (GS)

Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University, Atlanta, GA.

Jennifer A Sahatjian (JA)

Cheetah Medical, Wilmington, DE.

Eric Seeley (E)

Pulmonary, Critical Care Medicine and Allergy, University of California San Francisco, San Francisco, CA.

Wesley H Self (WH)

Department of Emergency Medicine, Vanderbilt University, Nashville, TN.

Jeremy A Weingarten (JA)

Pulmonary, Critical Care and Sleep Medicine, New York-Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY.

Mark Williams (M)

Pulmonary and Critical Care Medicine, Indiana University School of Medicine, Indianapolis, IN.

Douglas M Hansell (DM)

Cheetah Medical, Wilmington, DE; Department of Anesthesiology, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH